Home » Topics » Regulatory

Regulatory
RSS

Fixed-dose trandolapril/verapamil combination now available in U.K.

Nov. 25, 1997

Combivir recommended for approval in Europe

Nov. 24, 1997

Novartis launches once-monthly formulation of Sandostatin

Nov. 24, 1997

Doxil/Caelyx evaluated in phase II for advanced breast cancer

Nov. 24, 1997

FDA advisory committee recommends approval of Rocephin for AOM

Nov. 24, 1997

Floxin recommended for FDA approval

Nov. 21, 1997

Imutec licenses novel anticancer compounds from Ion

Nov. 21, 1997

Topical FK-506 for skin allograft rejection

Nov. 21, 1997

Bayer seeks FDA approval for metrifonate for Alzheimer's disease

Nov. 21, 1997

Beclometasone CFC-free MDI for chronic bronchial asthma approved

Nov. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld Science
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...